首页> 美国卫生研究院文献>International Journal for Parasitology: Drugs and Drug Resistance >Exploring the scope of new arylamino alcohol derivatives: Synthesis antimalarial evaluation toxicological studies and target exploration
【2h】

Exploring the scope of new arylamino alcohol derivatives: Synthesis antimalarial evaluation toxicological studies and target exploration

机译:探索新的芳基氨基醇衍生物的范围:合成抗疟疾评估毒理学研究和目标探索

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Synthesis of new 1-aryl-3-substituted propanol derivatives followed by structure-activity relationship, in silico drug-likeness, cytotoxicity, genotoxicity, in silico metabolism, in silico pharmacophore modeling, and in vivo studies led to the identification of compounds >22 and >23 with significant in vitro antiplasmodial activity against drug sensitive (D6 IC50 ≤ 0.19 μM) and multidrug resistant (FCR-3 IC50 ≤ 0.40 μM and C235 IC50 ≤ 0.28 μM) strains of Plasmodium falciparum. Adequate selectivity index and absence of genotoxicity was also observed. Notably, compound >22 displays excellent parasitemia reduction (98 ± 1%), and complete cure with all treated mice surviving through the entire period with no signs of toxicity. One important factor is the agreement between in vitro potency and in vivo studies. Target exploration was performed; this chemotype series exhibits an alternative antimalarial mechanism.
机译:合成新的1-芳基-3-取代的丙醇衍生物,然后进行结构-活性关系,计算机模拟药物,细胞毒性,基因毒性,计算机代谢,计算机药效团建模以及体内研究导致对化合物的鉴定 > 22 和> 23 具有对药物敏感(D6 IC50≤0.19μM)和多药耐药(FCR-3 IC50≤0.40μM和C235 IC50≤0.28μM)菌株的体外抗血浆活性恶性疟原虫。还观察到足够的选择性指数和没有遗传毒性。值得注意的是,化合物> 22 表现出出色的寄生虫减少率(98±1%),并且可以完全治愈,并且所有治疗的小鼠在整个生存期中都没有毒性迹象。一个重要因素是体外效价与体内研究之间的一致性。进行目标探索;该化学型系列展现出另一种抗疟机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号